Merck & Co., Inc. and NSTI Nanotech Now Accepting Abstracts for Consideration for the Merck & Co., Inc. Symposium on Targeted Delivery of siRNA

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Nano Science and Technology Institute (NSTI) is pleased to announce that abstracts are being accepted for the Merck Corporate Symposium: Targeted Delivery of siRNA, to be held during Nanotech 2008 in Boston, MA. The Symposium will provide an important platform for Merck to engage leading researchers in the nano tech community and create a discussion around the application of emerging nano technologies and their ability to affect targeted delivery of therapeutic siRNA molecules.

MORE ON THIS TOPIC